Literature DB >> 15611099

Phosphodiesterase 4D forms a cAMP diffusion barrier at the apical membrane of the airway epithelium.

Anthony P Barnes1, Gabriel Livera, Pingbo Huang, Chuanwen Sun, Wanda K O'Neal, Marco Conti, M Jackson Stutts, Sharon L Milgram.   

Abstract

We demonstrated previously that Calu-3 airway epithelial cells sense adenosine on their luminal surface through adenosine A2B receptors coupled to adenylyl cyclase. Occupancy of these receptors leads to activation of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel through protein kinase A (PKA) anchored at the apical membrane. Because luminal A2B receptor activation does not raise total cellular cAMP levels, we hypothesized that activation of phosphodiesterases (PDEs) confines cAMP generated by apical A2B receptors to a microdomain that includes the CFTR channel. Using reverse transcription-PCR, Western blotting, and activity measurements, PDE4D was identified as the major PDE species in airway epithelia. Consistent with these results, inhibitors of PDE4, but not PDE3, selectively abolished the lateral confinement of cAMP signaling in apical membrane patches during cell-attached recordings. Furthermore, stimulation of the CFTR in excised apical patches by rolipram and RS25344 indicated that PDE4 is localized in close proximity to the CFTR channel. Indeed, immunohistochemistry of human airway sections revealed that PDE4D is localized in the apical domain of the cell. PDE4 was activated after luminal adenosine exposure in a PKA-dependent manner. Because PDE4 activity is positively regulated by PKA, our results support a model whereby the PDE diffusion barrier is proportional to the degree of receptor stimulation. These findings underscore the concept that subcellular localization of individual PDE isozymes is an important mechanism for confining cAMP signaling to functional domains within cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15611099     DOI: 10.1074/jbc.M407521200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  CFTR regulation in human airway epithelial cells requires integrity of the actin cytoskeleton and compartmentalized cAMP and PKA activity.

Authors:  Stefania Monterisi; Maria Favia; Lorenzo Guerra; Rosa A Cardone; Domenico Marzulli; Stephan J Reshkin; Valeria Casavola; Manuela Zaccolo
Journal:  J Cell Sci       Date:  2012-02-02       Impact factor: 5.285

2.  A specific pattern of phosphodiesterases controls the cAMP signals generated by different Gs-coupled receptors in adult rat ventricular myocytes.

Authors:  Francesca Rochais; Aniella Abi-Gerges; Kathleen Horner; Florence Lefebvre; Dermot M F Cooper; Marco Conti; Rodolphe Fischmeister; Grégoire Vandecasteele
Journal:  Circ Res       Date:  2006-03-23       Impact factor: 17.367

3.  IBMX-elicited inhibition of water permeability in the isolated rabbit conjunctival epithelium.

Authors:  Oscar A Candia; Chi-Wing Kong; Lawrence J Alvarez
Journal:  Exp Eye Res       Date:  2007-12-23       Impact factor: 3.467

4.  Radixin assembles cAMP effectors Epac and PKA into a functional cAMP compartment: role in cAMP-dependent cell proliferation.

Authors:  Daniel Hochbaum; Guillermo Barila; Fernando Ribeiro-Neto; Daniel L Altschuler
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

5.  Anchored PDE4 regulates chloride conductance in wild-type and ΔF508-CFTR human airway epithelia.

Authors:  Elise Blanchard; Lorna Zlock; Anna Lao; Delphine Mika; Wan Namkung; Moses Xie; Colleen Scheitrum; Dieter C Gruenert; Alan S Verkman; Walter E Finkbeiner; Marco Conti; Wito Richter
Journal:  FASEB J       Date:  2013-11-07       Impact factor: 5.191

6.  Inactivation of multidrug resistance proteins disrupts both cellular extrusion and intracellular degradation of cAMP.

Authors:  Moses Xie; Thomas C Rich; Colleen Scheitrum; Marco Conti; Wito Richter
Journal:  Mol Pharmacol       Date:  2011-05-06       Impact factor: 4.436

7.  Characterizing the cancer genome in lung adenocarcinoma.

Authors:  Barbara A Weir; Michele S Woo; Gad Getz; Sven Perner; Li Ding; Rameen Beroukhim; William M Lin; Michael A Province; Aldi Kraja; Laura A Johnson; Kinjal Shah; Mitsuo Sato; Roman K Thomas; Justine A Barletta; Ingrid B Borecki; Stephen Broderick; Andrew C Chang; Derek Y Chiang; Lucian R Chirieac; Jeonghee Cho; Yoshitaka Fujii; Adi F Gazdar; Thomas Giordano; Heidi Greulich; Megan Hanna; Bruce E Johnson; Mark G Kris; Alex Lash; Ling Lin; Neal Lindeman; Elaine R Mardis; John D McPherson; John D Minna; Margaret B Morgan; Mark Nadel; Mark B Orringer; John R Osborne; Brad Ozenberger; Alex H Ramos; James Robinson; Jack A Roth; Valerie Rusch; Hidefumi Sasaki; Frances Shepherd; Carrie Sougnez; Margaret R Spitz; Ming-Sound Tsao; David Twomey; Roel G W Verhaak; George M Weinstock; David A Wheeler; Wendy Winckler; Akihiko Yoshizawa; Soyoung Yu; Maureen F Zakowski; Qunyuan Zhang; David G Beer; Ignacio I Wistuba; Mark A Watson; Levi A Garraway; Marc Ladanyi; William D Travis; William Pao; Mark A Rubin; Stacey B Gabriel; Richard A Gibbs; Harold E Varmus; Richard K Wilson; Eric S Lander; Matthew Meyerson
Journal:  Nature       Date:  2007-11-04       Impact factor: 49.962

8.  Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice.

Authors:  Sergey Udalov; Rio Dumitrascu; Soni S Pullamsetti; Hamza M Al-tamari; Norbert Weissmann; Hossein A Ghofrani; Andreas Guenther; Robert Voswinckel; Werner Seeger; Friedrich Grimminger; Ralph T Schermuly
Journal:  BMC Pulm Med       Date:  2010-05-05       Impact factor: 3.317

Review 9.  ABCD of the phosphodiesterase family: interaction and differential activity in COPD.

Authors:  David M G Halpin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  Persistent cAMP-signals triggered by internalized G-protein-coupled receptors.

Authors:  Davide Calebiro; Viacheslav O Nikolaev; Maria Cristina Gagliani; Tiziana de Filippis; Christian Dees; Carlo Tacchetti; Luca Persani; Martin J Lohse
Journal:  PLoS Biol       Date:  2009-08-18       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.